PPT-Post-autologous Transplant Therapy for Hodgkin Lymphoma

Author : sherrill-nordquist | Published Date : 2020-04-02

Program Goals cHL Overview cHL Poor Prognosis Risk Factors Case Study 1 45YearOld Man With EarlyStage cHL PostHDTASCT BV Maintenance Phase 3 AETHERA Trial Design

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document " Post-autologous Transplant Therapy for ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Post-autologous Transplant Therapy for Hodgkin Lymphoma: Transcript


Program Goals cHL Overview cHL Poor Prognosis Risk Factors Case Study 1 45YearOld Man With EarlyStage cHL PostHDTASCT BV Maintenance Phase 3 AETHERA Trial Design Phase 3 AETHERA Trial Efficacy Data. Virginia C. . Broudy. , MD. September 25, 2014. Presentation prepared by: . Presenter. Last Updated: . Date. AIDS-Defining Malignancies. Kaposi sarcoma . NHL – now has a higher incidence than Kaposi Sarcoma in the US. ymphoma. Sobia Ozair. March 8, 2017. MD Anderson Lecture Series. Indolent NHL include:. Follicular. CLL/SLL. Marginal . zone. Cutaneous T-cell. Anaplastic Large Cell . Lymphoma. Follicular NHL. Most . Lisbon 2018. #EBMT18. Tuesday 20 . March. . 2018. , . 07:00-09:00 –Room 3B. EBMT LWP Open Research Forum. Tuesday 20 March 2018,.  . 11:00-12:30 . - . Auditorium II. Lymphoma Working Party Session. Paige . klem. . Or consortium 2019. The Basics. What does autologous mean? . Cells . or tissues obtained from the same . individual. Reason for a skull flap? . . Craniectomy. : Surgical removal of a portion of the skull.. Introduction. Categories. Advantages and Disadvantages. Indications and contraindications. Preoperative Blood collection. Acute . Normovolemic. . Hemodilution. Intra and Post-operative Blood collection. lecture 3. Lecturer . Dr.Mohanad Al-Hindawi. MBCHB, MSc. Histopathology, . CABHS.Anatomical. pathology. Non-Hodgkin lymphoma-Clinical . features . Two thirds of NHLs and . (virtually all Hodgkin lymphomas) . Basics. Lymphoma – a cancer started in the cells of the immune system. 5 types:. Hodgkin Disease. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma in Children. Lymphoma of the Skin. Waldenstrom. . Macroglobulinemia. . . . Pathogenesis of EBV Infection. . Cohen . NEJM 2000. Early IM: NK cells. non-HLA specific CTLs. Late IM: HLA-restricted CTLs (CD8 and CD4):. Lytic epitopes - up to 40% of CD8 cells . 101 17 (1) , 101-104 Introduction Over the last decades with the advancements in diagnostics and treatment approaches, many cancer types can be expected to have excellent outcomes. Hodgkin lymphoma How to cite: Kusminsky G, Abriata G, Forman D, Sierra MS (2016).Etiology of Hodgkin lymphoma (C81) in Central and South America.In: Cancer in Central and South America.Lyon: International Agency for About Indolent Lymphoma Non-Hodgkin’s lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. 1 Types of NHL can be g Dr. Sanne Lugthart. (. Dr. Stephen Robinson). University Hospital Bristol. 20 June 2019. Scope Of Talk. Current CAR T products available for NHS patients. The CAR T pathway (up to re-infusion). Patients Cases. lymph nodes . Tonsils and adenoids (Waldeyer's ring) . Peyer's patches and appendix . White pulp of the spleen . Lymphadenopathy :. Localized (e.g., infection) or generalized (Systemic disease). . May be due to inflammatory, reactive or neoplastic disorders. A Pediatric Transplant Infectious Diseases . Learning Module. Using the interactive modules. The basic modules are designed . to take ~ 30 minutes to complete. , especially if you choose to investigate all of the .

Download Document

Here is the link to download the presentation.
" Post-autologous Transplant Therapy for Hodgkin Lymphoma"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents